LLY
Eli Lilly·NYSE
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 8
Bearish signal 1
Consensus Rating "Buy"
Ample Liquidity
High Gross Profit Margin
Significant Net Income Growth
High Cash/net Profit Ratio
EPS Beats Expectation
Price Hits New High
Low Beta
Revenue Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About LLY
Eli Lilly And Company
A global pharmaceutical leader with a diverse portfolio of innovative medicines and treatments for various diseases and conditions
Lilly Corporate Center, Indianapolis, Indiana 46285
Drug production and sales
Incorporated in Indiana in 1901, Eli Lilly was formerly a pharmaceutical manufacturer founded in 1876 by Colonel Eli Lilly in Indianapolis, Indiana. The company develops, manufactures and sells important pharmaceutical products. The company's mission is to combine "caring" with "discovery" to create a better life for people around the world.
Earnings Call
Q1/2025
Estimate EPS3.46
Actual EPS3.34
Estimate Revenue12.72B
Actual Revenue12.73B
Eli Lilly's Q1 2025: Navigating Contradictions in Innovation, Orforglipron Positioning, and Market Access Strategies
May 02,2025 12:49
Earnings Decrypt
Earnings Decrypt
Q2/2025
Estimate EPS5.58
Actual EPS6.31
Estimate Revenue14.67B
Actual Revenue15.56B
Eli Lilly's Q2 2025 Earnings Call: Unpacking Contradictions in Orforglipron's Efficacy, Pricing, and Supply Dynamics
Aug 11,2025 12:47
Earnings Decrypt
Earnings Decrypt
Q3/2025
Estimate EPS5.89
Actual EPS7.02
Estimate Revenue16.07B
Actual Revenue17.60B
Eli Lilly's Q3 2025: Contradictions Emerge on Orforglipron Pricing, Weight Maintenance, and CVS Formulary Impact
Nov 02,2025 03:19
Earnings Decrypt
Earnings Decrypt
Company Financials
EPS
LLY has released its 2025 Q3 earnings. EPS was reported at 7.02, versus the expected 5.89, beating expectations. The chart below visualizes how LLY has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
LLY has released its 2025 Q3 earnings report, with revenue of 17.60B, reflecting a YoY change of 53.87%, and net profit of 5.58B, showing a YoY change of 475.34%. The Sankey diagram below clearly presents LLY's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
